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Summary
Arc/Arg3.1 is an immediate-early gene whose expres-
sion levels are increased by strong synaptic activa-
tion, including synapse-strengthening activity pat-
terns. Arc/Arg3.1 mRNA is transported to activated
dendritic regions, conferring the distribution of Arc/
Arg3.1 protein both temporal correlation with the in-
ducing stimulus and spatial specificity. Here, we in-
vestigate the effect of increased Arc/Arg3.1 levels on
synaptic transmission. Surprisingly, Arc/Arg3.1 re-
duces the amplitude of synaptic currents mediated
by AMPA-type glutamate receptors (AMPARs). This ef-
fect is prevented byRNAi knockdown of Arc/Arg3.1, by
deleting a region of Arc/Arg3.1 known to interact with
endophilin 3 or by blocking clathrin-coated endocyto-
sis of AMPARs. In the hippocampal slice, Arc/Arg3.1
results in removal of AMPARs composed of GluR2
and GluR3 subunits (GluR2/3). Finally, Arc/Arg3.1 ex-
pression occludes NMDAR-dependent long-term de-
pression. Our results demonstrate that Arc/Arg3.1 re-
duces the number of GluR2/3 receptors leading to
a decrease in AMPAR-mediated synaptic currents,
consistent with a role in the homeostatic regulation
of synaptic strength.
Introduction
Brain processes like learning and memory are thought to
involve plastic changes in synaptic strength. It is there-
fore reasonable to postulate that cellular mechanisms
supporting these plastic changes would show both spa-
tial specificity and temporal correlation with the stimulus
that triggered the plastic change. Despite the abundant
evidence to connect synaptic plasticity with gene ex-
pression (Deisseroth et al., 2003), causal evidence to re-
late known gene products synthesized in the mamma-
lian cell soma to changes in specific sets of synapses
has been missing. The discovery of Arc/Arg3.1 in 1995
(Link et al., 1995; Lyford et al., 1995) revealed the only
known activity-induced gene that correlates both tem-
*Correspondence: cline@cshl.eduporally and spatially with the stimulus that induced its
transcription.
Arc/Arg3.1 (activity-regulated cytoskeleton-associ-
ated) is an effector immediate-early gene rapidly induced
by different forms of neuronal activity, e.g., LTP-inducing
stimuli (Lyford et al., 1995; Steward et al., 1998), pharma-
cological stimulation (Fosnaugh et al., 1995), and behav-
ioral stimulation (Guzowski et al., 1999; Montag-Sallaz
et al., 1999). Increases in Arc/Arg3.1 mRNA can be ob-
served 5 min after stimulation and may last over 8 hr (Cir-
elli and Tononi, 2000; Guzowski et al., 1999; Lyford et al.,
1995). The most striking characteristic of this immediate-
early gene is not only that its mRNA is transported to den-
drites, but also that it accumulates in the region of the
dendritic tree where the inducing stimulus arrived (Stew-
ard et al., 1998; Steward and Worley, 2001). Such a mech-
anism ensures the localization of Arc/Arg3.1 protein to
the region of dendrite that had received strong synaptic
activation. It should be noted, however, that there is no
evidence that Arc/Arg3.1 is targeted specifically to acti-
vated synapses.
Similar to LTP induction, Arc/Arg3.1 transcription and
mRNA localization depend on the activation of NMDA-
type glutamate receptors (NMDARs). Indeed, NMDAR
activation can also relocalize Arc/Arg3.1 mRNA which
had been previously induced (Lyford et al., 1995; Stew-
ard et al., 1998; Steward and Worley, 2001). Following in-
duction and mRNA localization, Arc/Arg3.1 protein is
found in dendritic spines (Moga et al., 2004), where it
can interact with components of the endocytic machin-
ery involved in AMPA receptor trafficking (Chowdhury
et al., 2006 [this issue of Neuron]).
Arc/Arg3.1 is expressed in glutamatergic neurons in
the hippocampus and neocortex. Its mRNA can be first
detected in rats at the eighth postnatal day (P8), and
basal levels increase steadily until P21 (Lyford et al.,
1995).Thisdevelopmental profilecorrelateswithaperiod
of synaptogenesis and synaptic rearrangement. In spite
of the interesting properties ofArc/Arg3.1 in terms of ac-
tivity induction, as well as mRNA and protein localization,
there has been no study to directly address the effect of
increased levels of Arc/Arg3.1 on synaptic transmission.
Here, we increase Arc/Arg3.1 expression in hippo-
campal CA1 pyramidal neurons to assay its effects on
synaptic properties. We find that Arc/Arg3.1 reduces
the amplitude of currents mediated by AMPARs, and
this is prevented by RNAi knockdown of Arc/Arg3.1.
After Arc/Arg3.1 protein has been localized to the syn-
apse, further synaptic activity is not required to mediate
its effect. We also show that this effect of Arc/Arg3.1
occurs through endocytosis of AMPARs containing
GluR2 but not GluR1 subunits in our system. The region
of Arc/Arg3.1 that interacts with endophilin 3 (Chowd-
hury et al., 2006), a component of the endocytic machin-
ery, is necessary for the effect. The Arc/Arg3.1-mediated
decrease in AMPAR transmission is sensitive to phos-
phatase inhibitors, and Arc/Arg3.1 expression occludes
long-term depression (LTD). Keeping in mind that Arc/
Arg3.1 is induced by strong stimuli, including LTP-in-
ducing stimuli, these results suggest that Arc/Arg3.1
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transmission following strong activity, suggesting a
homeostatic function.
Results
Recombinant Arc/Arg3.1 Expression
Strong synaptic activation increases levels of Arc/
Arg3.1 mRNA and protein between 2- and over 10-fold
over a period of 2 to more than 8 hr (Ons et al., 2004;
Steward et al., 1998; Wallace et al., 1998). To mimic
this increase, we expressed green fluorescent protein
(GFP)-tagged recombinant Arc/Arg3.1 in CA1 pyramidal
neurons in organotypic hippocampal slice cultures us-
ing a Sindbis virus expression system (Malinow et al.,
1999). We analyzed the time course of recombinant
Arc/Arg3.1 expression by GFP fluorescence and west-
ern blots (Figures 1A and 1C). We observed GFP fluores-
cence in pyramidal cell bodies starting 6 hr after virus in-
jection and in dendritic spines after 7 hr (Figure 1B and
see Figure S1 in the Supplemental Data available with
this article online; see Experimental Procedures). The re-
combinant protein can be first detected by western blot
6 hr after virus injection. We made electrophysiological
recordings 10 to 20 hr after virus injection to match the
time window of increased Arc/Arg3.1 expression re-
ported with activity-induced increases of endogenous
Arc/Arg3.1 mRNA and protein (Montag-Sallaz et al.,
1999; Wallace et al., 1998).
We also investigated the levels of recombinant Arc/
Arg3.1 expression. Our expression system induced
a median 8-fold increase in recombinant Arc/Arg3.1 ex-
pression compared to basal expression levels of endog-
enous Arc/Arg3.1 (Figures 1D and 1E; median, 7.89;
range, 1.89 to 23.14). This increase in Arc/Arg3.1 expres-
sion is comparable to previously reported increases in
mRNA and protein for endogenous Arc/Arg3.1, as well
as other activity-induced genes (Castren et al., 1993;
Guzowski et al., 2001; Matsuo et al., 2000; Ons et al.,
2004; Steward et al., 1998; Ying et al., 2002).
Arc/Arg3.1 Reduces AMPAR-Mediated
Synaptic Currents
In order to test whether increased Arc/Arg3.1 expres-
sion regulates synaptic transmission, we recorded
evoked postsynaptic currents in CA1 pyramidal cells us-
ing whole-cell voltage clamp. We recorded simulta-
neously from two neighboring cells: a control uninfected
cell and a cell expressing recombinant Arc/Arg3.1. This
recording technique allows the paired comparison of the
amplitudes of the responses of neighboring neurons in
response to the same stimulus, and controls for differ-
ences between slices that arise from variations in stim-
ulation electrode placement and stimulus intensity.
Arc/Arg3.1 induced a significant reduction (32%) in
AMPAR-mediated synaptic currents (Figures 2A, 2B,
and 2H; control median, 249.81 pA; IQR, 277.86 to
233.07; Arc/Arg3.1 median, 233.36 pA, IQR, 247.58 to
221.25). In contrast, expression of GFP alone had no im-
pact on AMPA-evoked excitatory postsynaptic currents
(EPSCs; Figures 2D and 2E; control median,244.77 pA;
IQR, 265.95 to 226.28; GFP median, 241.76 pA; IQR,
277.60 to 225.90). The effect of Arc/Arg3.1 on AMPA
EPSCs was significantly different from the effect ofGFP expression alone (Figure 2H). We did not observe
changes in rise or decay times (Figure S2). Moreover,
input resistance (Ri) at all recorded holding potentials,
as well as resting potentials (Vrest) were unaffected
in cells expressing recombinant Arc/Arg3.1 compared
to control neighbors (Mann-Whitney test: Ri, 260 mV,
p > 0.24; Ri, +40 mV, p > 0.79; Vrest, p > 0.23).
The amplitude of NMDAR-mediated currents was not
affected by increased Arc/Arg3.1 expression (Figures
2A, 2C, and 2I; control median, 19.38 pA; IQR, 14.05 to
31.08; Arc/Arg3.1 median, 19.06 pA; IQR, 12.37 to
27.25). The effect of Arc/Arg3.1 on NMDAR-mediated
currents was indistinguishable from the effect of ex-
pressing GFP alone. NMDAR-mediated currents in
GFP-expressing cells were not significantly different
from that of control neighboring cells (Figures 2D and
2F; control median, 16.75 pA; IQR, 10.82 to 23.03; GFP
median, 14.08 pA; IQR, 9.85 to 24.47). In addition, the
decay time constant of NMDAR-mediated currents in
Arc/Arg3.1-expressing cells did not differ from that of
control neighbors (Figure S2; control median, 78.9 ms;
IQR, 68.71 to 93.32; Arc/Arg3.1 median, 74.11ms; IQR,
63.1 to 97.38; Mann-Whitney, p > 0.39). Finally, GABAR-
mediated currents, rise and decay times were not signif-
icantly affected by Arc/Arg3.1 expression (Figures 2G
Figure 1. Recombinant Arc/Arg3.1 Expression Levels and Time
Course
(A) Epifluorescent images of slices injected in a single site in CA1.
Scale bar: 200 mm for both 43 and 103 objectives. The solid white
line indicates the edge of the slice. The dashed lines indicate the
different layers of the CA1 region: So: stratum oriens, Sp: stratum
pyramidale, Sr: stratum radiatum.
(B) Two-photon image of dendrites of a pyramidal cell showing the
localization of Arc/Arg3.1-GFP in dendritic spines. Scale bar: 10 mm.
(C) The time course of recombinant Arc/Arg3.1 (rARC) expression
assessed by western blot. Times shown are hours after virus injec-
tion.
(D) Relative expression levels of recombinant Arc/Arg3.1 and endog-
enous Arc/Arg3.1 (eARC) in three samples. The ratio for each exam-
ple is indicated below the blot.
(E) Box and whisker graph showing the recombinant to endogenous
Arc/Arg3.1 ratios. The bars indicate the range, the box the IQR, and
the line the median of the data.
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463Figure 2. Arc/Arg3.1 Reduces AMPAR-Medi-
ated Current Amplitudes
(A) AMPAR- and NMDAR-mediated EPSCs
from a control cell (left) and an neighboring
Arc/Arg3.1-expressing cell (right), recorded
simultaneously. Dotted lines indicate control
cell amplitudes. Scale bar: 10 pA, 10 ms.
(B and C) Arc/Arg3.1 depresses evoked
AMPAR- but not NMDAR-mediated synaptic
responses. Scatter plots of synaptic ampli-
tudes mediated by AMPARs (B) and NMDARs
(C) in Arc/Arg3.1-expressing cells (y axis)
and neighboring control cells (x axis). In this
and all subsequent scatter plots, each dot
represents a simultaneous paired recording.
Wilcoxon test significance is shown. Star
indicates median. Diagonal line indicates uni-
tary slope (y = x).
(D) Representative traces of AMPAR- and
NMDAR-mediated currents from a control
cell (left) and an neighboring GFP-expressing
cell (right). Scale bar: 10 pA, 10 ms.
(E and F) Viral expression of GFP does not af-
fect AMPAR- or NMDAR-mediated synaptic
currents. Scatter plots comparing amplitudes
of synaptic AMPAR (E)- and NMDAR (F)-me-
diated responses in GFP-expressing cells
(y axis) and neighboring control cells (x axis).
(G) Arc/Arg3.1 expression does not affect
GABAR-mediated synaptic transmission.
Scatter plot of the amplitude of GABAR-me-
diated IPSCs in Arc/Arg3.1-expressing cells
(y axis) and neighboring control cells (x axis).
(H and I) Amplitudes of AMPAR (H)- and
NMDAR (I)-mediated currents in infected
neurons normalized to neighboring control
neurons for GFP- and Arc/Arg3.1-infected
slices. Data are expressed as median and
IQR. Mann-Whitney test significance is
indicated.
(J–L) Arc/Arg3.1 decreases AMPAR mini am-
plitude, but not mini frequency. Cumulative
frequency of amplitudes for all AMPAR
mEPSC events (J) (Arc/Arg3.1: dashed line,
n = 2764; control: solid line, n = 3720). Kolmo-
gorov-Smirnov test significance is indicated.
AveragemEPSC amplitudes (K) andfrequency
(L) per cell, expressed as median and IQR.
Mann-Whitney test significance is indicated.and S1; control median, 157 pA; IQR, 94.79 to 286.21;
Arc/Arg3.1 median, 153.7 pA; IQR, 103.54 to 217.78).
These experiments indicate that Arc/Arg3.1 specifically
reduces AMPAR-mediated synaptic currents.
We also recorded spontaneous AMPAR miniature
EPSCs (mEPSCs). Increased Arc/Arg3.1 expression de-
creased the amplitude of mEPSCs by a comparable
amount to that observed in the evoked EPSCs (Figures
2J and 2K; 32% averaged across mEPSC events; 30%
averaged across cells). We found a nonsignificant de-
crease in mEPSC frequency (Figure 2L), likely due to
the fact that the mEPSC amplitude distribution for the
Arc/Arg3.1 group is closer to the event detection limit
(Figure 2J).
The Effect of Arc/Arg3.1 Is Constant over
Development
Basal levels of Arc/Arg3.1 increase during the first three
postnatal weeks in vivo (Lyford et al., 1995). During the
equivalent period in culture, the organotypic slices
also show a comparable developmental increase inArc/Arg3.1 basal levels (Figure 3A). In addition, organo-
typic slice cultures parallel other aspects of in vivo de-
velopment. For instance, both in vivo and in vitro, there
is an increase in synapse number, a decrease in the rate
at which synaptogenesis occurs, and changes in the
ability to induce plasticity (Buchs et al., 1993; De Simoni
et al., 2003; Hsia et al., 1998; Muller et al., 1993).
To test whether these developmental changes influ-
ence the effect of increased Arc/Arg3.1 expression
upon AMPAR-mediated currents, we recorded from
neurons expressing recombinant Arc/Arg3.1 in slices
maintained for 3 weeks in culture (WIC). Similar to 1
WIC slices, increased Arc/Arg3.1 expression also re-
duced AMPAR-mediated currents in 3 WIC slices (Fig-
ures 3B–3F; 34%).
Arc/Arg3.1 siRNA Blocks the Reduction of AMPA
Transmission
These previous experiments established that increased
levels of recombinant Arc/Arg3.1 reduce the amplitude
of AMPAR-mediated EPSCs. We tested this finding
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stant Overdevelopment
(A) Western blot showing the increase of
endogenous Arc/Arg3.1 (eARC) with time in
culture. The same blot reprobed with tubulin
antibody was used as a loading control.
(B) Simultaneous paired recordings of
AMPAR- and NMDAR-mediated currents
from a control cell (left) and a neighboring
Arc/Arg3.1-expressing cell (right) in a slice
after 3 WIC. Scale bar: 10 pA, 10 ms.
(C and D) Scatter plots of amplitudes of
evoked responses mediated by AMPARs (C)
and NMDARs (D) in Arc/Arg3.1-expressing
cells (y axis) and neighboring control cells
(x axis) recorded in slices after 3 WIC.
(E and F) Comparison of the effect of GFP and
Arc/Arg3.1 on AMPAR (E)- and NMDAR (F)-
mediated currents in slices after 1 or 3 WIC.
Responses of infected neurons are normal-
ized to neighboring control neurons. Mann-
Whitney significance is indicated.further using the opposite approach. Arc/Arg3.1 expres-
sion is normally low in unstimulated slices. Instead of
increasing Arc/Arg3.1 levels by viral expression of
recombinant protein, we increased endogenous Arc/
Arg3.1 through synaptic activation of the slice with a
brief application of picrotoxin (see Experimental Proce-
dures). In addition, we blocked the increased Arc/Arg3.1
expression in single cells using biolistic transfer of
a small interfering RNA (siRNA). Picrotoxin induces
strong recurrent synaptic activity in the hippocampal
slice and produces a 7- to 10-fold increase in Arc/
Arg3.1 protein (data not shown). This protocol allows
comparison of AMPAR-mediated transmission in cells
expressing high levels of endogenous Arc/Arg3.1 with
nearby cells in which Arc/Arg3.1 expression is blocked
by siRNA.
Control untransfected cells showed reduced AMPAR-
mediated EPSC amplitude compared to adjacent cells
transfected with Arc/Arg3.1 siRNA (Figures 4D and 4E;
control median, 233.3 pA; IQR, 243.96 to 219.57; Arc/
Arg3.1 siRNA median, 261.55 pA; IQR, 283.92 to
236.75). This effect was significantly different from the
effect of transfecting with control siRNA (Figure 4B),
which did not affect AMPAR-mediated currents (Figures
4G and 4H; control median, 248.75 pA; IQR, 269.61 to
228.74; control siRNA median, 243.3 pA; IQR, 277.43
to 222.79). Neither Arc/Arg3.1 siRNA nor control siRNA
affected NMDAR-mediated transmission (Figures 4C,
4D, 4F, 4G, and 4I).
Activity Does Not Regulate the Effect
of Arc/Arg3.1 Protein
Although it is known that Arc/Arg3.1 transcription and
mRNA localization are regulated by activity, it is unclear
whether the function of Arc/Arg3.1 protein is regulated
by activity after it has reached dendritic spines. To ad-dress this question, we exposed slices to treatments
that modify activity levels during the time of recombi-
nant Arc/Arg3.1 expression. As expected, recombinant
Arc/Arg3.1 expression is not susceptible to regulation
by neuronal activity in our system. Only the open reading
frame of Arc/Arg3.1 mRNA is expressed by the Sindbis
virus, and the virally driven mRNA synthesis does not
depend on cellular transcription factors. Incubation of
slices with the NMDAR antagonist APV, which prevents
endogenous Arc/Arg3.1 transcriptional induction and
mRNA localization (Steward and Worley, 2001), did not
prevent recombinant Arc/Arg3.1 localization to dendritic
spines (Figure 5B). As shown in Figure 5, the reduction in
AMPAR-mediated transmission persisted under treat-
ments that blocked NMDARs (200 mM DL-APV),
AMPARs (10 mM NBQX), generally reduced activity
levels (12 mM Mg2+, 2 mM TTX), blocked L-type Ca2+
channels (1 mM nifedipine), or metabotropic glutamate
receptors (mGluRs; 200 mM MCPG).
Arc/Arg3.1 Promotes GluR2-Containing
AMPAR Endocytosis
Considerable evidence suggests that synaptic depres-
sion results from the endocytosis of AMPARs (Kim
et al., 2001; Lee et al., 2002; Man et al., 2000; Seidenman
et al., 2003). Interaction of the cytoplasmic carboxy-
terminal tail of the AMPAR subunit GluR2 (GluR2 c-tail)
with the clathrin adaptor complex AP2 seems necessary
for the expression of LTD (Lee et al., 2002). The effect of
increased Arc/Arg3.1 expression differs from other
types of depression in terms of induction mechanism
and temporal window of expression. It is possible, how-
ever, that part of the molecular mechanisms involved in
the expression of transcription-independent forms of
depression could also participate in the effect induced
by increased levels of Arc/Arg3.1.
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465Figure 4. Arc/Arg3.1 siRNA Prevents the
Reduction of AMPA EPSCs
(A) Western blot of Cos-1 cells transfected
with the Arc/Arg3.1 complete coding se-
quence and siRNA againstArc/Arg3.1 or con-
trol siRNA. The same blot reprobed with b-tu-
bulin antibody was used as a loading control.
(B and C) Amplitudes of AMPAR (B)- and
NMDAR (C)-mediated currents in transfected
neurons normalized to neighboring control
neurons for control siRNA and Arc/Arg3.1
siRNA-transfected slices. Data are ex-
pressed as median and IQR. Mann-Whitney
test significance is indicated.
(D) Simultaneous paired recordings of
AMPAR- and NMDAR-mediated currents
from a control cell (left) and a neighboring
Arc/Arg3.1 siRNA-transfected cell (right).
Scale bar: 10 pA, 10 ms.
(E and F) Scatter plots of amplitudes of
evoked responses mediated by AMPARs (E)
and NMDARs (F) in Arc/Arg3.1 siRNA-trans-
fected cells (y axis) and neighboring control
cells (x axis).
(G) Simultaneous paired recordings of
AMPAR- and NMDAR-mediated currents
from a control cell (left) and a neighboring
control siRNA-transfected cell (right). Scale
bar: 10 pA, 10 ms.
(H and I) Scatter plots of amplitudes of
evoked responses mediated by AMPARs (H)
and NMDARs (I) in control siRNA-transfected
cells (y axis) and neighboring control cells
(x axis).To test whether GluR2-containing AMPAR endocyto-
sis is required for the reduction in AMPA EPSCs induced
by Arc/Arg3.1, we coexpressed Arc/Arg3.1 with pep-
AP2 (previously termed pepDA849–Q853; [Lee et al.,
2002]), a peptide that prevents the interaction between
GluR2 and the AP2 complex and abolishes clathrin-
coated vesicle endocytosis of GluR2-containing AMPARs.
As previously shown (Lee et al., 2002), pep-AP2 has
no significant effect on basal synaptic transmission
(Figures 6A and 6B). However, its coexpression with
Arc/Arg3.1 abolished Arc/Arg3.1-induced reduction in
AMPAR-mediated currents (Figures 6A and 6C). Synap-
tic transmission under this condition is indistinguishablefrom that recorded with pep-AP2 alone or GFP alone
(Figure 6D), and it is significantly different from trans-
mission recorded when Arc/Arg3.1 alone is expressed
(Mann-Whitney, p < 0.05).
Amino acids 91 to 100 of Arc/Arg3.1 interact with the
SH3 domain of endophilin 3 (Chowdhury et al., 2006),
a postsynaptic component of the clathrin-coated vesicle
endocytosis machinery. Chowdhury and coworkers also
demonstrated that a deletion mutant of Arc/Arg3.1 lack-
ing those amino acids does not interact with endophilin
3 and does not induce vesicle formation. To test if the
physiological effect of Arc/Arg3.1 we have recorded re-
lies on its molecular interaction with endophilin 3, weFigure 5. The Effect of Arc/Arg3.1 Is Indepen-
dent of Neuronal Activity
(A) AMPAR-mediated EPSC amplitudes from
GFP-expressing or Arc/Arg3.1-expressing
neurons under the conditions stated, ex-
pressed as median and IQR. NS: Wilcoxon,
p > 0.05; *Wilcoxon, p < 0.05.
(B) Two-photon image showing Arc/Arg3.1-
GFP localization to dendritic spines in slices
exposed to 200 mM DL-APV, a treatment
that prevents endogenous Arc/Arg3.1 mRNA
induction and localization. Scale bar: 10 mm.
(C) AMPAR response amplitudes from GFP-
and Arc/Arg3.1-expressing neurons nor-
malized to neighboring control neurons.
Arc/Arg3.1 depresses AMPAR-mediated re-
sponses even in the presence of drugs that
reduce activity levels. *p < 0.05 in Mann-
Whitney test and in Kruskal-Wallis with
Dunnett’s posthoc test.
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(A) Simultaneous paired recordings from control cells (left) and neighboring cells expressing GFP + pep-AP2 (right top) and Arc/Arg3.1 + pep-
AP2 (right bottom). Scale bar: 10 pA, 10 ms.
(B and C) Scatter plots of AMPAR response amplitudes in cells coexpressing GFP (B) or Arc/Arg3.1 (C) with pep-AP2 (y axis) and neighboring
control cells (x axis).
(D) AMPAR response amplitudes in GFP, GFP + pep-AP2, and Arc/Arg3.1 + pep-AP2 neurons normalized to responses in neighboring control
neurons. Kruskal-Wallis test significance is indicated.
(E) Simultaneous paired recordings from a control cell (left) and neighboring cell expressing Arc/Arg3.1(D91–100).
(F) Scatter plot of AMPAR response amplitudes for cells expressing Arc/Arg3.1(D91–100) (y axis) compared to neighboring control cells (x axis).
(G) Normalized AMPAR response amplitudes in cells expressing GFP alone or Arc/Arg3.1(D91–100). Mann-Whitney test significance is indicated.
(H) Image showing the localization of Arc/Arg3.1(D91–100) to dendritic spines.expressed Arc/Arg3.1(D91–100) (deletion mutant lack-
ing amino acids 91 to 100). Arc/Arg3.1(D91–100) does
not reduce AMPAR-mediated transmission (Figures 6E
and 6F). Furthermore, its effect is indistinguishable
from that of GFP expression alone (Figure 6G), and it
is significantly different from transmission recorded
when Arc/Arg3.1 alone is expressed (Mann-Whitney,
p < 0.05). The lack of effect of Arc/Arg3.1(D91–100) is
not due to exclusion of the recombinant protein from
dendritic spines (Figures 6H and S3).
In the CA3-to-CA1 synapse, there are two major sub-
populations of AMPARs: heteromers composed of
GluR2 and GluR3 subunits (GluR2/3) and heteromers
composed of GluR1 and GluR2 subunits (GluR1/2)
(Wenthold et al., 1996). In the hippocampal slice, these
receptor pools behave differently regarding trafficking
and membrane life times. We reasoned that if Arc/
Arg3.1 acts on GluR2/3 but not GluR1/2, then reducing
the number of synaptic GluR2/3 would occlude the ef-
fect of Arc/Arg3.1 on AMPAR-mediated transmission.
Expression of the GluR2 c-tail prevents delivery and
synaptic stabilization of GluR2/3 AMPARs, thereby re-
ducing their number and depressing basal transmission
(Shi et al., 2001). The effect of Arc/Arg3.1 coexpressed
with the GluR2 c-tail is indistinguishable from the effect
of GluR2 c-tail expression alone or that of Arc/Arg3.1
alone (Figures 7A–7D). The occlusion and lack of sum-
mation between the effects of expressing Arc/Arg3.1
and the GluR2 c-tail demonstrate that the mechanism
by which Arc/Arg3.1 reduces synaptic transmission
affects AMPAR heteromers composed of GluR2 and
GluR3 subunits.
To further test this selectivity for GluR2/3 AMPARs,
we biotinylated surface proteins in slices expressingeither recombinant Arc/Arg3.1 or GFP. The slices were
homogenized, and 20% of the total homogenate was
used to estimate total GluR2 or GluR1. The remaining
80% of the same homogenate was incubated with strep-
tavidin beads to precipitate the biotinylated surface pro-
teins. The samples were analyzed by western blot for
GluR2 or GluR1 in the total and biotinylated fractions
of the same homogenate. This protocol allows us to
compare changes in surface expression of the protein
induced by Arc/Arg3.1 expression, using GFP expres-
sion as a control. Slices with increased Arc/Arg3.1
expression have a smaller surface-to-total GluR2 ratio
than GFP-expressing slices (Figures 7E and 7F). Arc/
Arg3.1 expression did not affect the surface-to-total
ratio of the GluR1 subunit (Figures 7E and 7G).
We did not detect any GluR2 or GluR1 in the precipi-
tate when the biotinylation reagent was omitted, indicat-
ing that the precipitation of biotinylated GluR subunits
was specific (Figure 7E, GFP no biot. lanes). Finally,
probing for the intracellular proteins PICK1 and b-tubu-
lin in each experiment showed that the biotinylation was
specific for surface proteins (Figure 7E).
Increased Arc/Arg3.1 Expression Occludes
Long-Term Depression
Our data indicate that Arc/Arg3.1 reduces AMPAR-
mediated currents through a mechanism involving
GluR2/3 AMPAR endocytosis. Some forms of LTD also
result in AMPAR endocytosis (Man et al., 2000; Wang
and Linden, 2000). If the Arc/Arg3.1-mediated decrease
in AMPAR transmission shares the same mechanisms of
expression as LTD, then Arc/Arg3.1 should occlude
LTD. Indeed, cells with increased levels of Arc/Arg3.1
failed to express LTD (Figure 8A). Simultaneous
Arc/Arg3.1 Reduces AMPAR-Mediated Currents
467Figure 7. Arc/Arg3.1 Decreases Surface GluR2/3 AMPARs
(A) Simultaneous paired recordings from control cells (left) and neighboring cells coexpressing the GluR2 c-tail (GluR2 ct.) with either GFP (right
top) or Arc/Arg3.1 (right bottom). Scale bar: 10 pA, 10 ms.
(B and C) Scatter plots of AMPAR response amplitudes for cells coexpressing GFP (B) or Arc/Arg3.1 (C) with GluR2 c-tail (y axis) compared to
neighboring control cells (x axis).
(D) Normalized AMPAR response amplitudes in cells expressing Arc/Arg3.1, GFP + GluR2 c-tail, and Arc/Arg3.1 + GluR2 c-tail. Kruskal-Wallis
test significance is indicated.
(E) Examples of western blots showing the total protein lane (20% of the homogenate) and the adjacent biotinylated protein lane (precipitated
from the remaining 80% of the same homogenate). Examples of GluR2 and GluR1 western blots from slices expressing GFP or Arc/Arg3.1.
Control experiments of the binding to the streptavidin beads in the absence of biotinylation reagent (GFP NO BIOT.), and of intracellular protein
biotinylation (PICK1 and b-tubulin).
(F) Median and IQR of surface to total protein ratio for GluR2, normalized to the median ratio for GFP-expressing slices. Mann-Whitney signif-
icance is indicated.
(G) Same as (F) for GluR1.recordings from recombinant Arc/Arg3.1-expressing
cells and adjacent control cells demonstrate occlusion.
While the amplitude of transmission in cells expressing
Arc/Arg3.1 did not change after LTD induction, trans-
mission onto control cells decreased to the same ampli-
tude as recorded from the Arc/Arg3.1 cells (Figure 8B).
Although the distinct mechanisms for induction of
Arc/Arg3.1 and LTD clearly differentiate the two pro-
cesses, they appear to share some common mecha-
nisms of expression. To test this possibility further,
we incubated the slices in two compounds commonly
used to block NMDAR-dependent LTD (Morishita
et al., 2001; Mulkey et al., 1994). Okadaic acid (1 mM)
and FK506 (50 mM), inhibitors of Protein Phosphatase
1 and Calcineurin, respectively, blocked the effect of
Arc/Arg3.1 on AMPAR-mediated transmission but did
not affect the localization of the recombinant protein
to spines (Figures 8C–8J).
Discussion
Arc/Arg3.1 Specifically Reduces AMPAR-Mediated
Synaptic Currents
In this study, we showed that increased Arc/Arg3.1 ex-
pression, that mimics the levels and time window of ac-
tivity-dependent endogenous Arc/Arg3.1 upregulation
(Figure 1), reduces AMPAR-mediated synaptic currents
without affecting NMDAR-mediated current amplitudesor decay time constants. Furthermore, synaptic currents
mediated by the GABAR were unaffected by increased
Arc/Arg3.1 expression (Figure 2). The observation that
increased Arc/Arg3.1 levels had similar effects on
evoked and miniature AMPAR-mediated currents, but
no impact on evoked NMDAR-mediated currents, sug-
gests that Arc/Arg3.1 reduces AMPAR-mediated trans-
mission through a postsynaptic mechanism affecting
AMPA receptor number and, together with input resis-
tances and resting potentials identical to those of con-
trol cells, argues against nonspecific effects of the
expression system. Reducing activity levels did not
prevent the Arc/Arg3.1-induced reduction of AMPAR
EPSCs (Figure 5), showing that activity does not regu-
late the effect of Arc/Arg3.1 protein after it has been lo-
calized, consistent with the fact that the localization of
Arc/Arg3.1 is activity regulated at the transcriptional
and mRNA localization level. Moreover, we observed
the same magnitude of Arc/Arg3.1 effect in slices cul-
tured for 1 or 3 weeks (Figure 3). This not only shows
that the effect of increased Arc/Arg3.1 expression is
constant throughout development, but it also argues
against a negative impact of Arc/Arg3.1 on synaptogen-
esis that could have also resulted in reduction of the
evoked currents. If that had been the case, we should
have seen a bigger effect of Arc/Arg3.1 in the younger
slices, when synaptogenesis is occurring at a more
rapid rate (De Simoni et al., 2003).
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(A) LTD recordings in cells with increased levels of recombinant Arc/Arg3.1 (gray squares) and control cells (black circles). Average EPSC am-
plitude normalized to the mean baseline amplitude. Mann-Whitney significance, comparing Arc/Arg3.1 and control cells, over the last 5 min is
indicated.
(B) Simultaneous paired LTD recordings from neurons expressing recombinant Arc/Arg3.1 and uninfected neighboring cells. Average absolute
amplitudes are shown. Mann-Whitney significance, comparing Arc/Arg3.1 and adjacent control cells, is indicated for the baseline and last 5 min.
(C and G) Simultaneous paired recordings of AMPAR-mediated currents from a control cell (left) and a neighboring Arc/Arg3.1-infected cell
(right), in slices treated with 1 mM okadaic acid (C) or 50 mM FK506 (G). Scale bar: 10 pA, 10 ms.
(D and H) Scatter plots of amplitudes of evoked responses mediated by AMPARs in Arc/Arg3.1-infected cells (y axis) and neighboring control
cells (x axis), in slices treated with okadaic acid (D) or FK506 (H).
(E and I) Amplitudes of AMPAR-mediated currents in infected neurons normalized to neighboring control neurons for GFP-infected slices and
Arc/Arg3.1-infected slices treated with okadaic acid (E) or FK506 (I). Data are expressed as median and IQR. Mann-Whitney test significance
is indicated.
(F and J) Images showing the localization of recombinant Arc/Arg3.1 to dendritic spines in slices treated with okadaic acid (F) or FK506 (J).We also performed the reverse experiment, in which
we stimulated synaptic activity in slices to induce en-
dogenous Arc/Arg3.1 upregulation in control cells. In
those slices, cells transfected with an siRNA to reduce
Arc/Arg3.1 expression showed higher AMPAR-medi-
ated transmission levels than the control cells in which
endogenous Arc/Arg3.1 expression was not blocked
(Figure 4). In other words, preventing Arc/Arg3.1 up-reg-
ulation caused the opposite effect of increasing its ex-
pression. This demonstrates that cells with increased
levels of Arc/Arg3.1, either recombinant or endogenous,
exhibit reduced AMPAR EPSC amplitude compared to
neurons with low Arc/Arg3.1 levels. It also shows that
the increases in Arc/Arg3.1 levels induced by our re-
combinant expression system are functionally compa-
rable to those occurring during activity-dependent
Arc/Arg3.1 induction.
A previous study linked Arc/Arg3.1 expression to LTP
maintenance showing reduced potentiation and learn-
ing deficits after injection of antisense oligos against
Arc/Arg3.1 (Guzowski et al., 2000). Additionally, genetic
removal of Arc/Arg3.1 shows similar effects on learning
and potentiation (Plath et al., 2006 [this issue ofNeuron]). In our hands, preventing Arc/Arg3.1 expres-
sion with RNAi leads to an absolute increase of AMPA
transmission in RNAi-transfected cells compared to
controls. Considering that increased basal AMPA trans-
mission reduces the potentiation levels after LTP induc-
tion (Shi et al., 2001) and impairs performance in the
Morris Water Maze (Moser et al., 1998), the result by
Guzowski and colleagues can be explained by an
increase in basal transmission levels rather than a deficit
in LTP maintenance.
Arc/Arg3.1 Promotes GluR2/3 Endocytosis
Previous work proposed a role for clathrin-coated vesi-
cle endocytosis in synaptic depression (Carroll et al.,
2001). The cytoplasmic tail of the GluR2 subunit inter-
acts with the adaptor protein complex AP2, a compo-
nent of the clathrin-coated vesicle endocytosis machin-
ery that promotes the assembly of the clathrin-coated
pit (Kirchhausen, 1999). Lee and coworkers (2002) char-
acterized this interaction and generated a peptide that
interferes with it (termed here pep-AP2). They showed
that, despite its lack of effect in basal transmission,
the peptide blocks NMDAR-dependent LTD. This
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on AMPAR-mediated synaptic transmission (Figure 6),
suggesting that clathrin-coated vesicle endocytosis of
GluR2-containing AMPARs is necessary for the effect
of Arc/Arg3.1 upon synaptic transmission. In addition,
the region of Arc/Arg3.1 that mediates its interaction
with endophilin 3 (Chowdhury et al., 2006), a postsynap-
tic component of the clathrin-coated vesicle endocyto-
sis machinery, is necessary for the electrophysiological
effect of Arc/Arg3.1 (Figure 6). This result further con-
firms the involvement of AMPAR endocytosis and indi-
cates a molecular mechanism.
Regulated trafficking of AMPAR into and out of the
synapse governs some forms of synaptic plasticity
(Bredt and Nicoll, 2003; Malinow and Malenka, 2002).
In the hippocampus, AMPARs are mainly divided in
two subpopulations: GluR1/2 heteromers, and GluR2/3
heteromers (Wenthold et al., 1996). Several studies
have attempted to distinguish the cell biological proper-
ties of GluR1/2 heteromers from those of GluR2/3 het-
eromers. Synaptic depression appears to rely on endo-
cytosis of AMPARs containing the GluR2 subunit
(Chung et al., 2003; Kim et al., 2001; Man et al., 2000;
Seidenman et al., 2003), while exocytosis of GluR1/2
mediates synaptic potentiation (Shi et al., 1999, 2001).
GluR2/3 AMPARs have a shorter life time in the
plasma membrane than GluR1/2 heteromers in primary
cultures (Passafaro et al., 2001). In the hippocampal
slice culture, recombinant GluR1/2 receptors do not re-
place a significant proportion of endogenous receptors
in 24 hr, but that is not the case for recombinant GluR2/3.
Furthermore, ectopic expression of the GluR1 c-tail has
no effect on basal transmission but prevents the activ-
ity-dependent delivery of GluR1/2. Conversely, ectopic
expression of the GluR2 c-tail depresses basal synaptic
transmission, prevents GluR2/3 insertion, but does not
affect the activity-dependent insertion of GluR1/2 (Shi
et al., 2001). These results illustrate that GluR2/3 recep-
tors cycle into and out of the synapse faster and are
more labile than GluR1/2 in the hippocampal slice.
Decreasing synaptic GluR2/3 receptors by GluR2 c-
tail expression occluded the effect of Arc/Arg3.1 on syn-
aptic transmission (Figure 7), supporting our interpreta-
tion that Arc/Arg3.1 acts primarily on the labile AMPAR
pool that is mainly composed of GluR2/3 heteromers. Fi-
nally, biotinylation of surface receptors showed that sur-
face expression of GluR2 is reduced in Arc/Arg3.1-ex-
pressing slices without an effect on surface GluR1
(Figure 7). Wenthold and coworkers (1996) estimated
that approximately 42% of the AMPA-binding receptors
in the hippocampus are GluR2/3 heteromers, a slightly
higher proportion are GluR1/2 receptors, and about
8% are homomeric GluR1. In the light of those results,
reduced surface GluR2 in the absence of a reduction
in surface GluR1 indicates that the effect of Arc/Arg3.1
is mainly upon GluR2/3 heteromers. This is consistent
with our interpretation of the electrophysiological data
and suggests that the magnitude of our effect (w32%
reduction in AMPA response) results from removal of
a significant proportion of the GluR2/3-containing re-
ceptors from the cell surface.
It is worth noting that the slow recycling of GluR1/2
compared to GluR2/3 in the hippocampal slice culture
(Kolleker et al., 2003; Shi et al., 2001) probably causedthe observed selectivity of Arc/Arg3.1 for GluR2/3. In pri-
mary cultured neurons, where GluR1/2 recycling is
much faster and takes place in the minute time scale,
Arc/Arg3.1 also induced a reduction in surface GluR1
(Chowdhury et al., 2006). The results in both experimen-
tal systems suggest that the selectivity of the effect
of Arc/Arg3.1 for a particular receptor pool may not
be governed by Arc/Arg3.1 itself, but by the rate at
which the different receptor pools become available
for endocytosis.
Arc/Arg3.1 and LTD: Shared Mechanisms,
Different Functions
Our results indicate that Arc/Arg3.1 and LTD converge at
the same end point, the removal of synaptic AMPAR.
This also suggested that at least some of the mecha-
nisms underlying this receptor removal could be shared.
Consistent with this idea, we found that increased Arc/
Arg3.1 expression occluded LTD (Figure 8). The effect
of Arc/Arg3.1 was also blocked by phosphatase inhibi-
tors that block NMDAR-dependent LTD. This indicates
that the pathways leading to AMPAR removal used by
Arc/Arg3.1 and NMDAR-dependent LTD share the
same sensitivity to phosphatase inhibitors. The molecu-
lar intermediaries between the activity of these phos-
phatases and AMPAR removal remain unknown.
Although increased Arc/Arg3.1 expression and differ-
ent forms of LTD result in endocytosis of GluR2-contain-
ing AMPARs (Kim et al., 2001; Man et al., 2000; Wang
and Linden, 2000), several distinctions between Arc/
Arg3.1 and LTD suggest that they have different func-
tions with respect to cellular and circuit plasticity.
Low-frequency stimulation leading to LTD does not in-
duce Arc/Arg3.1 transcription, mRNA localization, or
an increase in Arc/Arg3.1 protein levels. High-frequency
stimulation, which results in LTP, induces Arc/Arg3.1
transcription and transport of the mRNA to activated
dendritic regions (Steward et al., 1998; Steward and
Worley, 2001) and increased protein levels, as detected
by electron microscopy (Moga et al., 2004). The trans-
port of Arc/Arg3.1 mRNA to dendrites takes 30 to 60
min, and it may be longer before Arc/Arg3.1 protein ac-
cumulates to functional levels in spines (Steward et al.,
1998), while the induction of LTD takes 15 min or less
(Dudek and Bear, 1992). Finally, NMDAR or mGluR an-
tagonists do not block the effect of Arc/Arg3.1 (Figure 4),
but they do block two different forms of LTD (Oliet et al.,
1997). These differences in induction mechanism and
time course suggest that the function of Arc/Arg3.1 ex-
pression following strong synaptic activation may serve
a different cellular purpose.
Potential Consequences of Arc/Arg3.1 Action
Since its discovery in screens using massive electrocon-
vulsive shock or drug-induced seizures to induce activ-
ity-regulated genes (Link et al., 1995; Lyford et al., 1995),
it has been speculated that Arc/Arg3.1 could participate
in the stabilization of long-lasting synaptic changes in-
duced by activity, leading to learning and memory. Con-
sistent with this idea, LTP-inducing, but not LTD-induc-
ing, stimuli increase Arc/Arg3.1 expression (Steward
et al., 1998). In addition, experience can upregulate
Arc/Arg3.1 expression, as has been shown in CA1 pyra-
midal cells from animals exposed to environmental
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470novelty (Guzowski et al., 1999). However, Arc/Arg3.1 ex-
pression is also increased in response to injuring stimuli
like experimentally induced ischemia (Berger et al.,
2003; Kunizuka et al., 1999), electroconvulsive shock
(Lyford et al., 1995), and drug-induced seizures (Link
et al., 1995), where the postulated role for Arc/Arg3.1
in stabilizing enhanced synaptic strength may not
hold. Moreover, while the ability to induce LTP in the vi-
sual cortex decreases with age after the critical period
(Kirkwood et al., 1995), robust Arc/Arg3.1 mRNA induc-
tion can be detected in response to visual activity in 13-
week-old mice (Tagawa et al., 2005). The function ofArc/
Arg3.1 in the refinement of orientation selectivity is also
inconsistent with a role in synaptic strengthening (Wang
et al., 2006). The direct relationship between Arc/Arg3.1
expression levels and learning has also been challenged
(Kelly and Deadwyler, 2002; Kelly and Deadwyler, 2003).
Taken together, the published literature on Arc/Arg3.1
indicates that Arc/Arg3.1 is induced in response to any
strong enhancement of synaptic activity; however, until
now, no study has tested the functional consequences
of increased Arc/Arg3.1 expression with regard to syn-
aptic transmission. An intriguing possibility, compatible
with the literature onArc/Arg3.1, is thatArc/Arg3.1 func-
tions in the homeostatic regulation of synaptic strength.
In addition to mechanisms of synaptic plasticity, such
as LTP and LTD, neuronal cells possess mechanisms to
maintain synaptic strength within a range that allows fur-
ther increases or decreases in synaptic transmission
(Burrone et al., 2002; Desai et al., 2002; O’Brien et al.,
1998; Rabinowitch and Segev, 2006). It is thought that
without such homeostatic mechanisms, long-lasting
potentiation and depression would drive synapses to-
ward either saturation or silence (Miller, 1996; Miller
and Mackay, 1994). Strengthening the idea that synaptic
homeostasis is necessary for the proper coding of infor-
mation, Moser and coworkers (1998) showed that satu-
ration of synaptic strength is detrimental for learning. It
is, therefore, reasonable to postulate that activity-in-
duced genes, like Arc/Arg3.1, whose protein products
are localized to activated dendritic regions, may play
a role in local synaptic homeostasis after being up-
regulated by strong synaptic activation.
Indeed, homer 1a, an activity-dependent gene whose
induced expression correlates with that of Arc/Arg3.1 in
CA1 neurons (Vazdarjanova et al., 2002), has also been
shown to reduce synaptic currents (Sala et al., 2003).
Furthermore, the activity-dependent gene cpg-2 has
been recently implicated in the regulation of glutamate
receptor endocytosis (Cottrell et al., 2004). Another ac-
tivity-inducible gene, the polo-like kinase SNK, contrib-
utes to the loss of dendritic spines after being up-regu-
lated (Pak and Sheng, 2003). SNK also reduces the
synaptic levels of PSD-95, a scaffolding molecule in-
volved in the regulation of AMPAR-mediated currents
(El-Husseini et al., 2000).
As in our systemArc/Arg3.1 upregulation leads to a re-
duction in AMPA transmission through GluR2/3 re-
moval, recently potentiated synapses with its higher
GluR1/2 content would be less affected. As the model
in Figure 9 suggests, in such a scenario Arc/Arg3.1
would impose a threshold to potentiation, it would in-
crease the potentiated-to-nonpotentiated synaptic-
strength ratio, and at the same time it would homeostati-cally regulate total transmission levels. This model is
consistent with data from Wang and colleagues (2006),
who showed that, in orientation selective neurons in
the visual system, Arc/Arg3.1 is involved in suppressing
responses to nonpreferred orientations without affect-
ing preferred orientation-driven responses. In that
case, the synapses being strengthen by the preferred
orientation responses could induce Arc/Arg3.1 tran-
scription and localization with the consequent reduction
in the AMPA content of less-potentiated synapses be-
longing to the nonpreferred orientations.
The reduction we observed in the amplitude of
AMPAR-mediated synaptic current amplitudes upon
increased Arc/Arg3.1 expression is consistent with a
homeostatic role for activity-induced Arc/Arg3.1 upre-
gulation, as also suggested by Shepherd et al. (2006;
this issue of Neuron). Our results are supported by the
biochemical analysis of Arc/Arg3.1 (Chowdhury et al.,
2006) and by the role of Arc/Arg3.1 in the refinement of
orientation selectivity (Wang et al., 2006). Our data, and
data from other activity-induced genes, open the possi-
bility for a concerted action of such genes to maintain
synaptic strengths within a functional operating range.
Experimental Procedures
Recombinant Protein Expression, Slice Preparation,
and Infection
The Arc/Arg3.1 ORF fused to EGFP was obtained from Dr. Chowd-
hury in pEGFP-C3 (Clontech). Arc/Arg3.1(D91–100) was obtained
Figure 9. Model for Arc/Arg3.1 Action
The schematic illustrates the scenario in which a region of the den-
drite receives a synapse-strengthening stimulus that causes differ-
ent amounts of potentiation in three neighboring synapses and
induces Arc/Arg3.1 mRNA expression and localization to that
region. Synapse 1 is 100% potentiated, synapse 2 is not potentiated,
and synapse 3 is 50% potentiated. Arc/Arg3.1 preferentially affects
synapses with relatively more GluR2/3 content. Consequently, the
potentiated-to-nonpotentiated synaptic-strength ratio is increased
by Arc/Arg3.1-induced GluR2/3 removal, e.g., synapse 1-to-syn-
apse 2 ratio: initially 1, becomes 2 after LTP and increases to 3 after
Arc/Arg3.1 has acted. In addition, total synaptic strength for that
dendritic region is homeostatically regulated (initially 6, becomes 9
after LTP, returning to 6 after Arc/Arg3.1’s action).
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C3 (Clontech). Coexpression vectors were constructed in pCITE (In-
vitrogen). Pep-AP2 (pepDA849–Q853) was generously provided by
Dr. Morgan Sheng and has been previously described (Lee et al.,
2002). The GluR2 c-tail has also been described (Shi et al., 2001). Af-
ter the plasmids containing the genes of interest were prepared, the
inserts were transferred into pSinRep5 (Invitrogen) to produce repli-
cation-deficient Sindbis virus as described (Malinow et al., 1999).
Organotypic hippocampal slices were prepared from postnatal 5-
to 7-day-old rats as previously described (Stoppini et al., 1991) and
cultured for 6 to 9 days, unless noted, in culture medium (Musleh
et al., 1997). Recombinant protein expression in CA1 pyramidal neu-
rons was achieved by pressure injection of the viral stock with 0.1%
fast green using a sharp glass pipette and a Picospritzer (General
Valve Co.). When drugs were used, they were added to the culture
medium immediately after virus injection. With the exception of the
experiment in DL-APV, the extracellular recording solution did not
contain the drug, and the recording time was limited to less than
40 min. Recombinant protein distribution and localization to den-
dritic spines was unaffected by drug treatments.
We addressed the time course of Arc/Arg3.1 expression qualita-
tively by performing 160 identical virus injections in ten groups of
four slices each. Consistently with the Sindbis literature, no fluores-
cent protein expression could be observed before 4 hr. At 4 hr, some
fluorescent glial cells could be observed, but no pyramidal neurons.
At 6 hr, all 16 injection sites examined showed a few fluorescent pyr-
amids. At 7 hr, the first recognizable spines appeared, although not
fully loaded. Distal dendrites were not visible or very faint. After 9 hr,
the density of fluorescent pyramids per injection site was substan-
tial, distal dendrites, and spines were visible (Figure S1).
Electrophysiological Recordings and Data Analysis
Electrophysiological recordings were obtained 10 to 20 hr after virus
injection, from CA1 pyramidal neurons locatedw200 mm from the in-
jection site to ensure an infection density low enough to identify non-
infected cells with ease. Slices were perfused with artificial cerebro-
spinal fluid (pH 7.4) at 29C containing 119 mM NaCl, 2.5 mM KCl,
4 mM CaCl2, 4 mM MgCl2, 26 mM NaHCO3, 1 mM NaH2PO4,
11 mM D-glucose, 0.1 mM picrotoxin, and 0.004 mM 2-chloroadeno-
sine gassed with 5% CO2-95% O2. The only exception was the
AMPA mEPSC recordings (1mM MgCl2 was used instead of 4 mM,
and 2 mM TTX was added) and the recordings of GABAR-mediated
currents, in which the picrotoxin was omitted. Patch recording
pipettes (3–6 MU) were filled with intracellular solution (pH 7.25),
containing 115 mM cesium methanesulfonate, 20 mM ClCs, 10 mM
HEPES, 2.5 mM MgCl2, 4 mM Na2ATP, 0.4 mM Na3GTP, 10 mM so-
dium phosphocreatine, and 0.6 mM EGTA, with the exception of the
resting potential recordings, in which a potassium-based intracellu-
lar solution was used.
Whole-cell voltage-clamp recordings (or current clamp to mea-
sure the resting potentials) were made simultaneously with Axo-
patch-1D amplifiers (Axon Instruments) in infected and control unin-
fected cells separated by less than 5–10 mm, but in most cases
adjacent. Synaptic responses were evoked with single voltage
pulses (200 ms, 1–10V) using bipolar electrodes placed in stratum ra-
diatum, 100 to 200 mm from the pyramidal layer. Responses were
evoked every 3 s with a stimulus intensity set to evoke AMPAR-me-
diated responses of around 230 to 250 pA. This range allows us to
reliably detect increases and decreases in amplitudes. AMPAR-me-
diated responses were recorded at 260 mV, NMDAR-mediated re-
sponses at +40 mV, and GABAR-mediated responses at 0 mV. The
average of 50 to 100 responses at each holding potential was
used to calculate the current amplitudes. AMPAR- and GABAR-me-
diated current amplitudes were calculated at the peak of the re-
sponse; NMDAR-mediated current amplitudes were computed 50
ms after the stimulation as the average over 5 ms of recording. Cells
were visualized using oblique illumination in a Zeiss Axioskop micro-
scope with a 603 water-immersion objective. Infected cells were
identified using epifluorescence illumination with filter settings suit-
able for GFP. LTD was induced with 1 Hz stimulation for 5 min at210
mV of holding potential. Test responses were evoked every 3 s, and
five responses were averaged to obtain every data point. The data
were digitized with an ITC-18 board (Instrutech) and acquired with
an IgorPro-based (Wavemetrics) custom software.For all experiments, holding current, series, and input resistance
were monitored, and no significant difference was observed
between infected and uninfected or transfected cells at any holding
potential.
Data analysis and statistics were performed in Matlab (Math-
works). All decay time constants were obtained by fitting the re-
sponses to a single exponential. The data sets were probed for nor-
mality using Shapiro-Wilk’s test. Because all data sets could not be
assumed to be normally distributed, nonparametric statistics were
used and medians with interquartile ranges (IQR) are shown instead
of mean with standard error of the mean. The only exception is the
LTD data, which satisfied normality and distributional symmetry cri-
teria. Normalization of the data using Box-Cox transformation and
testing using parametric methods did not change significance in
any case. Wilcoxon paired test was used to compare infected
against uninfected evoked EPSC amplitudes in each experiment.
When comparisons were made across different experiments, the
infected/uninfected amplitude ratio for every cell pair was used.
Mann-Whitney test was used to compare two groups and Kruscal-
Wallis to compare more than two groups. The significance threshold
was set at p = 0.05 for all tests. For all the experiments in which the
Wilcoxon test p value is less than 0.05, comparison against the effect
of GFP expression alone using Mann-Whitney also shows signifi-
cance and vice versa. The percent reduction in AMPAR-mediated
currents reported is the median of the reduction for every pair in
the data set referred to.
Arc/Arg3.1 RNAi
Fifty picomoles of predesigned Arc/Arg3.1 siRNAs (Ambion) or
a control siRNA bearing no homology to known genes (Ambion
cat#4611) were cotransfected with pCMV-Arc/Arg3.1 (a plasmid
containing the whole coding sequence for Arc/Arg3.1 under the
CMV promoter) into Cos-1 cells (60% confluent in 60 mm diameter
plates) in a 100:1 molar ratio using Lipofectamine 2000 (Invitrogen)
following manufacturer’s specifications. The following day, the cells
were scraped in PBS with 1% Triton X-100, 0.2% SDS, and protease
inhibitor cocktail (CompleteMini, Roche), homogeneized, and centri-
fuged at 4C for 4 min at 1000 3 g. The supernatant was used for
western blot against Arc/Arg3.1 and reprobing for b-tubulin as
explained below. One Arc/Arg3.1 siRNA (Ambion ID#199057; GCU
GAUGGCUACGACUACA) produced more than 90% knockdown
compared to sister plates transfected with the control siRNA.
Gene Gun bullets were prepared using 12.5 mg of 1.6 mm diameter
gold spheres and 3 mg of that siRNA + 10 mg pEGFP (Clontech)
following the procedure detailed in the Helios Gene Gun (Bio-Rad)
manual. Hippocampal cultured slices were transfected using the bi-
olistics method. The following day the slices were exposed for 5 min
to 100 mM picrotoxin, washed, and incubated with fresh culture me-
dium for 3 to 10 hr before recording following the procedure outlined
above. Eight slices exposed to the picrotoxin treatment and eight
control slices were processed for Arc/Arg3.1 western blot, the pro-
tein content of the extracts was measured by the Bradford method,
and equal amount of protein of picrotoxin-treated and control ex-
tracts were loaded into adjacent lanes of a 7% gel for PAGE-SDS.
The western blot was performed as outlined below and the picro-
toxin-treated-to-control Arc/Arg3.1 ratio ranged from 7 to 10.
Arc/Arg3.1 Western Blot
Organotypic slices were homogenized in glass-teflon homogenizer
(1200 rpm) on ice-cold Tris-HCl 25 mM (pH 7.4) with 320 mM sucrose
and protease inhibitors (CompleteMini, Roche) and centrifuged at
13,0003 g for 15 min at 4C. The pellet was resuspended and loaded
in a 7% gel for PAGE-SDS. The proteins were transferred to nitrocel-
lulose membranes and incubated with anti-Arc/Arg3.1 rabbit poly-
clonal antibody at 1:5000. Horseradish peroxidase-conjugated sec-
ondary antibody (Bio-Rad 170-6515) at a 1:3000 dilution and ECL
chemoluminescence (Amersham) were used for detection.
For the recombinant Arc/Arg3.1 to endogenous Arc/Arg3.1 ratio
western blots, slices received multiple viral injections, spaced 100
to 150 mm, spanning all CA1 area. These multiple injections and
spacing ensures a very high infection efficiency (see below). Four-
teen hours later, only the area of CA1 showing the highest infection
rate was dissected under a fluorescent magnifying scope. The dis-
sected regions were processed as described above. For the time
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ral stock with the same pipette, injection duration, and pressure. The
slices were processed at the indicated time points and stored at
280C until used.
Quantification of the western blots to calculate recombinant Arc/
Arg3.1 to endogenous Arc/Arg3.1 ratios was done using Fluorchem
scanner and software (Alpha Innotech). The exposure times and
scanning parameters were optimized to minimize signal saturation.
Rectangular sections of the same area were used to calculate inte-
grated density values (IDV) over a band, and background above
and below the band were averaged. IDV values minus background
were used to calculate the ratios.
Surface Biotinylation
Slices received multiple viral injections, spaced 100 to 150 mm, span-
ning the entire CA1 area to ensure a high density of infection. The
percent infected cells was calculated by counting the fraction of
DAPI-stained nuclei showing green fluorescence in the same field
of view (median infected cells, 85.3%; range, 65.7% to 97.1%; n =
19). Surface biotinylation in slices was performed as described (Riv-
era et al., 2004; Thomas-Crusells et al., 2003) with minor modifica-
tions. Slices were washed in ice-cold ACSF three times for 5 min
and incubated on ice for 45 min in ACSF gassed with 5% CO2-
95% O2 containing 100 mM of NHS-SS-biotin (Sigma B5161). To
block the remaining reactive biotinylation reagent, the slices were
washed twice for 5 min in 100 mM lysine. The CA1 region showing in-
tense fluorescence was dissected and homogenized in teflon-glass
homogenizer (1200 rpm) in 20 mM Tris-HCl (pH 7.5), 50 mM NaCl,
1 mM EDTA, 1% Triton X-100, 0.1% SDS and protease inhibitors
(Complete Mini EDTA-free, Roche). The homogenate was centri-
fuged 5 min at 4C > 10000 3 g. The supernatant volume was mea-
sured and 20% of it separated to load in the total protein lane. The
remaining 80% of the homogenate was taken to 1 ml with ACSF
and rotated overnight at 4C with 40 ml of streptavidin beads (Ultra-
link, Pierce). The beads were precipitated at 3500 3 g for 1 min, the
supernatant discarded, and 13 Laemmli buffer added. The samples
were boiled 5 min and electrophoresed as described for the Arc/
Arg3.1 western blot. The antibodies used were as follows: GluR2
1:500 (Chemicon AB1768), GluR1 1:200 (Chemicon AB1504),
PICK1 1:50 (Upstate 07-293), and b-tubulin 1:2000 (Santa Cruz Bio-
technology sc-9104). Band intensities were quantified as described
for the Arc/Arg3.1 western blots. The surface-to-total ratios, (surface
density 2 background)/(total density 2 background), were normal-
ized to the median value for the GFP control. To ensure linearity, sev-
eral exposures were quantified for every experiment. The surface-
to-total ratio was constant over the chosen exposures with
a mean percent variation between the largest and smallest ratio of
under 2.6% in all cases (three different exposures). The middle expo-
sure was used for the quantifications and examples shown. We also
normalized total GluR1 or GluR2 to b-tubulin in the same lane in or-
der to measure total amounts of each subunit. We did not detect
changes in total GluR1 or GluR2 in Arc/Arg3.1-expressing slices
compared to GFP-expressing slices.
Imaging
The images were obtained on a custom two-photon excitation laser
scanning microscope, acquired, and the stacks flattened with Fluo-
view software (Olympus).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/3/461/DC1/.
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